NCT00157300View on ClinicalTrials.gov

PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

March 31, 2010

Study Completion Date

July 31, 2010

Conditions
Patients Receiving a Kidney From a Non-Heart-Beating Donor
Interventions
DRUG

Epoetin beta

intravenous, 33000 IU, 3 consecutive days, starting 3-4 hours before transplantation. Total dose 100.000 IU.

Trial Locations (2)

2300 RC

Leiden University Medical Center, Leiden

Unknown

Other transplantation centers, To Be Determined

All Listed Sponsors
lead

Leiden University Medical Center

OTHER

NCT00157300 - PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation | Biotech Hunter | Biotech Hunter